Skip to main content

FDA approves new ALS drug that costs $158,000 a year

Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.